Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

CCardiff Oncology, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
C

Cardiff Oncology, Inc.

$1.08Close · Oct 9, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $104K. Net result −$9.23M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $104K. Running result $104K. Revenue: $104K.
  • Cost of revenue: $0. Running result $104K.
  • Gross profit: $104K. Running result $104K.
  • Research and development: −$5.92M. Running result −$5.81M.
  • Selling, general and administrative: −$3.8M. Running result −$9.62M.
  • Operating income: −$9.62M. Running result −$9.62M.
  • Other income: $383K. Running result −$9.23M.
  • Pre-tax loss: −$9.23M. Running result −$9.23M.
  • Income tax benefit: $0. Running result −$9.23M.
  • Net loss: −$9.23M. Running result −$9.23M.